Agriculture

  • Meeting Notice of the National Agricultural Research, Extension, Education, and Economics Advisory Board

    AGENCY: Research, Education, and Economics, USDA.

    ACTION: Notice of meeting.


    SUMMARY: In accordance with the Federal Advisory Committee Act, the National Agricultural Research, Extension, and Teaching Policy Act of 1977, and the Agricultural Act of 2014, the United States Department of Agriculture (USDA) announces a meeting of the National Agricultural Research, Extension, Education, and Economics Advisory Board.

    DATES: May 16-18, 2017. The public may file written comments before or up to June 1, 2017.

    ADDRESSES: Hilton Crystal City at Washington Reagan National Airport, 2399 Jefferson Davis Highway, Arlington, Virginia 22202.

    Written comments may be sent to: The National Agricultural Research, Extension, Education, and Economics Advisory Board Office, Room 332A, Whitten Building, United States Department of Agriculture, STOP 0321, 1400 Independence Avenue SW., Washington, DC 20250-0321.

    FOR FURTHER INFORMATION CONTACT: Michele Esch, Executive Director/ Designated Federal Official, or Shirley Morgan-Jordan, Program Support Coordinator, National Agricultural Research, Extension, Education, and Economics Advisory Board; telephone: (202) 720-3684; fax: (202) 720- 6199; or email: nareee@ars.usda.gov.

    https://www.gpo.gov/fdsys/pkg/FR-2017-04-10/html/2017-07024.htm

  • Plant Variety Protection Board; Open Teleconference Meeting

    AGENCY: Agricultural Marketing Service, USDA.

    ACTION: Notice of meeting.


    SUMMARY: Pursuant to the Federal Advisory Committee Act (FACA), the Agricultural Marketing Service (AMS) is announcing a meeting of the Plant Variety Protection Board (Board). The meeting is being held to discuss a variety of topics including, but not limited to, work and outreach plans, subcommittee activities, and proposals for procedure changes. The meeting is open to the public. This notice sets forth the schedule and location for the meeting.

    DATES: Thursday, April 27, 2017, 10:00 a.m. to 12:00 p.m.

    ADDRESSES: The meeting will be held at the United States Department of Agriculture (USDA), Room 3543, South Building, 1400 Independence Avenue SW., Washington, DC 20250.

    FOR FURTHER INFORMATION CONTACT: Maria Pratt, Program Analyst, USDA, AMS, Science and Technology Programs, 1400 Independence Avenue SW., Washington, DC 20250. Telephone: (202) 260-898; Fax: (202) 260-8976, or Email: maria.pratt@ams.usda.gov.

    https://www.gpo.gov/fdsys/pkg/FR-2017-04-11/html/2017-07214.htm

  • Environmental Protection Agency

  • Board of Scientific Counselors Executive Committee; Notification of Public Teleconference and Public Comment

    AGENCY: Environmental Protection Agency (EPA).

    ACTION: Notification of public meeting and public comment.


    SUMMARY: Pursuant to the Federal Advisory Committee Act, Public Law 92- 463, the U.S. Environmental Protection Agency hereby provides notice that the Board of Scientific Counselors (BOSC) Executive Committee (EC) will host a public teleconference. The meeting will be held on Tuesday, April 11, 2017 from 1:00 p.m. to 5:00 p.m. All times noted are Eastern Time and are approximate. The primary agenda items include:

    Deliberate on the draft Homeland Security Subcommittee report; finalize and approve the BOSC subcommittee reports for the Air, Climate and Energy, Chemical Safety for Sustainability, Safe and Sustainable Water Resources, and Sustainable and Healthy Communities Research Programs; and finalize and approve the cross-cutting research annual reports for Environmental Justice, Climate Change, Children's Environmental Health, and Nitrogen and Co-pollutants. There will be a public comment period at 1:25 p.m. For information on registering to participate on the call or to provide public comment, please see the SUPPLEMENTARY INFORMATION section below. Due to unforeseen administrative circumstances, EPA is announcing this meeting with less than fifteen calendar days' notice.

    DATES: The BOSC EC meeting will be held on Tuesday, April 11, 2017 from 1:00 p.m. to 5:00 p.m. All times noted are Eastern Time and are approximate.

    FOR FURTHER INFORMATION CONTACT: Questions or correspondence concerning the meeting should be directed to Tom Tracy, Designated Federal Officer, Environmental Protection Agency, by mail at 1200 Pennsylvania Avenue NW., (MC 8104 R), Washington, DC 20460; by telephone at 202-564- 6518; fax at 202-565-2911; or via email at tracy.tom@epa.gov.

    https://www.gpo.gov/fdsys/pkg/FR-2017-04-10/html/2017-07150.htm

  • Evaluation of Existing Regulations

    AGENCY: Environmental Protection Agency (EPA).

    ACTION: Request for comment.


    SUMMARY: In accordance with Executive Order 13777, "Enforcing the Regulatory Reform Agenda,'' EPA is seeking input on regulations that may be appropriate for repeal, replacement, or modification.

    DATES: Comments must be received on or before May 15, 2017.

    ADDRESSES: Submit your comments, identified by Docket ID No. EPA-HQ-OA- 2017-0190 at http://www.regulations.gov. Follow the online instructions for submitting comments. Once submitted, comments cannot be edited or removed from Regulations.gov. The EPA may publish any comment received to its public docket. Do not submit electronically any information you consider to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. Multimedia submissions (audio, video, etc.) must be accompanied by a written comment. The written comment is considered the official comment and should include discussion of all points you wish to make. The EPA will generally not consider comments or comment contents located outside of the primary submission (i.e. on the web, cloud, or other file sharing system). For additional submission methods, the full EPA public comment policy, information about CBI or multimedia submissions, and general guidance on making effective comments, please visit http://www2.epa.gov/dockets/commenting-epa-dockets.

    FOR FURTHER INFORMATION CONTACT: For further information on this document, please contact Sarah Rees, Director, Office of Regulatory Policy and Management, Office of Policy, 1200 Pennsylvania Avenue NW., Mail Code 1803A, Washington, DC 20460, Phone: (202) 564-1986; Laws-Regs@epa.gov.

    https://www.gpo.gov/fdsys/pkg/FR-2017-04-13/html/2017-07500.htm

  • Health and Human Services

  • Agency Information Collection Activities: Proposed Collection; Comment Request

    AGENCY: Agency for Healthcare Research and Quality, HHS.

    ACTION: Notice.


    SUMMARY: This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the proposed information collection project "AHRQ Research Reporting System (ARRS).''

    This proposed information collection was previously published in the Federal Register on January 11, 2017 and allowed 60 days for public comment. AHRQ did not receive any substantive comments during this period. The purpose of this notice is to allow an additional 30 days for public comment.

    DATES: Comments on this notice must be received by May 11, 2017.

    ADDRESSES: Written comments should be submitted to: AHRQ's OMB Desk Officer by fax at (202) 395-6974 (attention: AHRQ's desk officer) or by email at OIRA_submission@omb.eop.gov (attention: AHRQ's desk officer).

    FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports Clearance Officer, (301) 427-1477, or by email at doris.lefkowitz@AHRQ.hhs.gov.

    https://www.gpo.gov/fdsys/pkg/FR-2017-04-11/html/2017-07156.htm

  • Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID)

    In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee:

    Times and Dates: 8:30 a.m.-5:00 p.m., EDT, May 3, 2017; 8:30 a.m.- 12:00 p.m., EDT, May 4, 2017.

    Place: CDC, Global Communications Center, 1600 Clifton Road NE., Building 19, Auditorium B3, Atlanta, Georgia 30329.

    Status: The meeting is open to the public, limited only by the space available. The meeting room will accommodate up to 100 people.

    Purpose: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: Strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers.

    Matters for Discussion: The meeting will include updates from CDC's infectious disease national centers; reports from the BSC's Food Safety Modernization Act Surveillance Working Group and Infectious Disease Laboratory Working Group; and focused discussions on priority emerging infectious diseases including antimicrobial resistance, influenza, and selected zoonotic and vector-borne diseases.

    Agenda items are subject to change as priorities dictate.

    Contact Person for More Information: Robin Moseley, M.A.T., Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop D10, Atlanta, Georgia 30329, Telephone: (404) 639- 4461.

    The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

    https://www.gpo.gov/fdsys/pkg/FR-2017-04-12/html/2017-07323.htm

  • Genome Editing in New Plant Varieties Used for Foods; Extension of Comment Period

    AGENCY: Food and Drug Administration, HHS.

    ACTION: Notification; extension of comment period.


    SUMMARY: The Food and Drug Administration (FDA or we) is extending the comment period for a docket to receive information and comments on the use of genome editing techniques to produce new plant varieties that are used for human or animal food. We established the docket through a notice that appeared in the Federal Register of January 19, 2017. We are taking this action in response to requests for an extension to allow interested persons additional time to submit comments.

    DATES: We are extending the comment period on the notice that published January 19, 2017 (82 FR 6564). Submit either electronic or written comments by June 19, 2017. Late, untimely filed comments will not be considered. The https://www.regulations.gov electronic filing system will accept comments until midnight Eastern Time at the end of June 19, 2017. Comments received by mail/hand delivery/courier (for written/ paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date.

    ADDRESSES: You may submit comments as follows:

    Electronic Submissions

    Submit electronic comments in the following way:

    Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else's Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov.

    If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see "Written/Paper Submissions'' and "Instructions'').

    Written/Paper Submissions

    Submit written/paper submissions as follows:

    Mail/Hand delivery/Courier (for written/paper submissions): Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

    For written/paper comments submitted to the Division of Dockets Management, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in "Instructions.''

    Instructions: All submissions received must include the Docket No. FDA 2016-N-4389 for "Genome Editing in New Plant Varieties Used for Foods." Received comments, those filed in a timely manner (see DATES), will be placed in the docket and, except for those submitted as "Confidential Submissions," publicly viewable at https://www.regulations.gov or at the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.

    Confidential Submissions--To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states "THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION." We will review this copy, including the claimed confidential information, in our consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Division of Dockets Management. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as "confidential." Any information marked as "confidential'' will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA's posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.

    Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the "Search'' box and follow the prompts and/or go to the Division of Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

    FOR FURTHER INFORMATION CONTACT:

    Regarding human food issues: Jason Dietz, Center for Food Safety and Applied Nutrition (HFS-205), Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-2282.

    Regarding animal food issues: Kathleen Jones, Center for Veterinary Medicine (HFV-220), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-5938.

    https://www.gpo.gov/fdsys/pkg/FR-2017-04-13/html/2017-07469.htm

  • Human Studies Review Board; Notification of Public Meetings

    AGENCY: Environmental Protection Agency (EPA).

    ACTION: Notice.


    SUMMARY: The Environmental Protection Agency (EPA), Office of the Science Advisor announces two separate public meetings of the Human Studies Review Board (HSRB) to advise the Agency on the ethical and scientific review of research involving human subjects.

    DATES: A virtual public meeting will be held on Thursday, April 27, 2017, from 1:00 p.m. to approximately 4:00 p.m. Eastern Time. A separate, subsequent teleconference meeting is planned for Friday, June 9, 2017, from 2:00 p.m. to approximately 3:30 p.m. Eastern Time for the HSRB to finalize its Final Report of the April 27, 2017 meeting and review other possible topics.

    ADDRESSES: Both of these meetings will be conducted entirely by telephone and on the Internet using Adobe Connect. For detailed access information visit the HSRB Web site: http://www2.epa.gov/osa/human-studies-review-board.

    FOR FURTHER INFORMATION CONTACT: Any member of the public who wishes to receive further information should contact the HSRB Designated Federal Official (DFO), Jim Downing on telephone number (202) 564-2468; fax number: (202) 564-2070; email address: downing.jim@epa.gov; or mailing address: Environmental Protection Agency, Office of the Science Advisor, Mail code 8105R, 1200 Pennsylvania Avenue NW., Washington, DC 20460.

    https://www.gpo.gov/fdsys/pkg/FR-2017-04-12/html/2017-07134.htm

  • Office of the Director, Office of Science Policy; Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the meeting of the National Science Advisory Board for Biosecurity (NSABB).

    Name of Committee: National Science Advisory Board for Biosecurity.

    Date: May 11, 2017.

    Time: 2:00 p.m.-4:30 p.m. Eastern.

    Agenda: Presentations and discussions regarding: (1) The Blue Ribbon Panel draft report on the 2014 variola virus incident on the NIH Bethesda campus; (2) stakeholder engagement on implementation of the U.S. Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern (DURC); and (3) other business of the Board.

    Place: Telephone conference call only (no in-person meeting), Public Dial-in (US Toll Free): 1-866-939-3921, Confirmation Number: 44675525.

    Contact Person: Jessica Tucker, Ph.D., Executive Director, NSABB, NIH Office of Science Policy, 6705 Rockledge Drive, Suite 750, Bethesda, Maryland 20892, (301) 451-4431, jessica.tucker@nih.gov.

    Under authority 42 U.S.C. 217a, section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established the National Science Advisory Board for Biosecurity (NSABB) to provide advice regarding federal oversight of dual use research-- defined as legitimate biological research that generates information and technologies that could be misused to pose a biological threat to public health and/or national security.

    The toll-free teleconference line will be open to the public at 1:30 p.m. to allow time for operator-assisted check-in. Members of the public planning to participate in the teleconference may also pre- register online via the link provided below or by calling Palladian Partners, Inc. (Contact: Carly Sullivan at 301-318-0841). Pre- registration will close at 12:00 p.m. Eastern on May 8, 2017. After that time, attendees may register their information with the teleconference operator upon dialing into the meeting. Individuals who plan to participate and need special assistance should submit a request to the contact person listed on this notice by May 3, 2017.

    Meeting materials: The meeting agenda, background material, and online pre-registration will be available at: https://palladianpartners.cvent.com/nsabbmay2017. Please check this Web site for updates.

    Public Comments: Time will be allotted on the agenda for the delivery of oral public comments. Members of the public interested in delivering prepared comments relevant to the mission of the NSABB should indicate so upon registration. Sign-up for delivering prepared oral comments will be limited to one per person or organization representative per open comment period. Individual comments will be time-limited to facilitate broad participation from multiple speakers.

    In addition, interested persons may file written comments at any time with the Board via an email sent to nsabb@od.nih.gov or by regular mail sent to the Contact Person listed on this notice. Written statements should include the name, contact information, and when applicable, the professional affiliation of the interested person. Written comments received by 12:00 p.m. Eastern on May 8, 2017 will be relayed to the NSABB prior to the teleconference meeting. Any written comments received after this deadline will be provided to the Board either before or after the meeting, depending on the volume of comments received and the time required to process them in accordance with privacy regulations and other applicable federal policies.

    https://www.gpo.gov/fdsys/pkg/FR-2017-04-13/html/2017-07511.htm

  • Regulation of Intentionally Altered Genomic DNA in Animals; Extension of Comment Period

    AGENCY: Food and Drug Administration, HHS.

    ACTION: Notice of availability; extension of comment period.


    SUMMARY: The Food and Drug Administration (FDA or we) is extending the comment period for the draft guidance for industry (GFI) #187 entitled "Regulation of Intentionally Altered Genomic DNA in Animals" that was announced in the Federal Register of January 19, 2017. We are taking this action in response to requests for an extension to allow interested persons additional time to submit comments.

    DATES: We are extending the comment period on the draft guidance published January 19, 2017 (82 FR 6561). Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that we consider your comment on this draft guidance, submit either electronic or written comments on the draft guidance by June 19, 2017.

    ADDRESSES: You may submit comments as follows:

    Electronic Submissions

    Submit electronic comments in the following way:

    Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else's Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov.

    If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see "Written/Paper Submissions" and "Instructions").

    Written/Paper Submissions

    Submit written/paper submissions as follows:

    Mail/Hand delivery/Courier (for written/paper submissions): Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

    For written/paper comments submitted to the Division of Dockets Management, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in "Instructions."

    Instructions: All submissions received must include the Docket No. FDA-2008-D-0394 for "Regulation of Intentionally Altered Genomic DNA in Animals." Received comments will be placed in the docket and, except for those submitted as "Confidential Submissions," publicly viewable at https://www.regulations.gov or at the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.

    Confidential Submissions--To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states "THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION." The Agency will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Division of Dockets Management. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as "confidential." Any information marked as "confidential'' will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA's posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.

    Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the "Search" box and follow the prompts and/or go to the Division of Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

    FOR FURTHER INFORMATION CONTACT: Laura R. Epstein, Center for Veterinary Medicine (HFV-1), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 301-796-8558, laura.epstein@fda.hhs.gov.

    https://www.gpo.gov/fdsys/pkg/FR-2017-04-13/html/2017-07470.htm

  • Interior

  • 2017 National Call for Nominations for Resource Advisory Councils

    AGENCY: Bureau of Land Management, Interior.

    ACTION: Notice.


    SUMMARY: The purpose of this notice is to request public nominations for the Bureau of Land Management (BLM) Resource Advisory Councils (RAC) that have members whose terms are scheduled to expire. RACs provide advice and recommendations to the BLM on land use planning and management of the National System of Public Lands within their geographic areas.

    DATES: All nominations must be received no later than May 30, 2017.

    ADDRESSES: Nominations and completed applications for RACs should be sent to the appropriate BLM offices listed in the SUPPLEMENTARY INFORMATION section of this notice.

    FOR FURTHER INFORMATION CONTACT: Twinkle Thompson, BLM Communications, 1849 C Street NW., Room 5645, Washington, DC 20240, 202-208-7301.

    https://www.gpo.gov/fdsys/pkg/FR-2017-04-12/html/2017-07371.htm

  • State

  • Nominations for Coordinating Lead Authors, Lead Authors, or Review Editors on the Second and Third Special Reports to be Undertaken by the Intergovernmental Panel on Climate Change During the Sixth Assessment Report (AR6) Cycle

    The United States Department of State, in cooperation with the United States Global Change Research Program, seeks nominations for U.S. scientists with requisite expertise to serve as Coordinating Lead Authors, Lead Authors, or Review Editors on the second and third Special Reports to be undertaken by the Intergovernmental Panel on Climate Change (IPCC) during the Sixth Assessment Report (AR6) cycle. The outlines for "Climate Change and Land: An IPCC Special Report on climate change, desertification, land degradation, sustainable land management, food security, and greenhouse gas fluxes in terrestrial ecosystems" and for the "IPCC Special Report on the Ocean and Cryosphere in a Changing Climate" were adopted at the 45th session of the IPCC Plenary.

    Nominations may be submitted at https://contribute.globalchange.gov/; additional information can be found at http://www.globalchange.gov/notices. This is an Open Call. All registered users can nominate U.S. citizens and permanent lawful residents to be considered by the IPCC Science Steering Committee (SSC). The call for nominations will close on May 15th, 2017, and a nominations package will be transmitted on behalf of the U.S. IPCC Focal Point on May 17th. The SSC will complete its work and issue appointment memos in late July 2017.

    The United Nations Environment Programme (UNEP) and the World Meteorological Organization (WMO) established the IPCC in 1988. In accordance with its mandate and as reaffirmed in various decisions by the Panel, the major activity of the IPCC is to prepare comprehensive and up-to-date assessments of policy-relevant scientific, technical, and socio-economic information for understanding the scientific basis of climate change, potential impacts, and options for mitigation and adaptation.

    https://www.gpo.gov/fdsys/pkg/FR-2017-04-14/html/2017-07596.htm

back to Federal Register Resource

Bookmark and Share


Trending News

Latest Twitter

Newsletter

Subscribe to our newsletter, sent out every month.